When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Research in Social and Administrative Pharmacy
- Vol. 17 (1), 1954-1963
- https://doi.org/10.1016/j.sapharm.2020.04.032
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Azithromycin Protects against Zika Virus Infection by Upregulating Virus-Induced Type I and III Interferon ResponsesAntimicrobial Agents and Chemotherapy, 2019
- Pharmacist role in vaccination: Evidence and challengesVaccine, 2019
- Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization processThe Journal of Antibiotics, 2019
- Macrolides in critically ill patients with Middle East Respiratory SyndromeInternational Journal of Infectious Diseases, 2019
- Fake News: Medicines Misinformation by the MediaClinical Pharmacology & Therapeutics, 2018
- Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trialAntiviral Research, 2017
- Zika virus cell tropism in the developing human brain and inhibition by azithromycinProceedings of the National Academy of Sciences of the United States of America, 2016
- Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adultsEmergencias, 2016
- Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st centuryInternational Journal of Antimicrobial Agents, 2007
- Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2005